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Background: Discrete Choice Experiments (DCEs) are increasingly used in studies in healthcare research but there
is still little empirical evidence for the predictive value of these hypothetical situations in similar real life
circumstances. The aim of this paper is to compare the stated preferences in a DCE and the accompanying
questionnaire with the revealed preferences of young parents who have to decide whether to vaccinate their new
born child against hepatitis B.
Methods: A DCE asking parents to decide in which scenario they would be more inclined to vaccinate their child
against hepatitis B. The stated preference was estimated by comparing the per respondent utility of the most
realistic scenario in which parents could choose to vaccinate their child against hepatitis B, with the utility of the
opt-out, based on the mixed logit model from the DCE. This stated preference was compared with the actual
behaviour of the parents concerning the vaccination of their new born child.
Results: In 80% of the respondents the stated and revealed preferences corresponded. The positive predictive
value is 85% but the negative predictive value is 26%.
Conclusions: The predictive value of the DCE in this study is satisfactory for predicting the positive choice but
not for predicting the negative choice. However, the behaviour in this study is exceptional in the sense that
most people chose to vaccinate. Future studies should focus on behaviours with a larger variance in the
population.
Keywords: DCE, Predictive value, Stated preferences, Revealed preferences, Vaccination, Hepatitis BBackground
Discrete Choice Experiments (DCEs) are increasingly
used to better understand how patients make health care
decisions [1], (e.g. [2,3]). A critique of DCEs is that their
predictive value may be restricted as they measure stated
(i.e. costless and effortless) preferences and actual behav-
iour may differ from these stated preferences [1,4-6].
A basic assumption of DCEs is that people base their
choices on latent preferences and seek to maximize their* Correspondence: mattijs.lambooij@rivm.nl
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unless otherwise stated.utility [7,8]. In most DCEs the respondents are asked to
imagine that they find themselves facing a choice and to
reveal which alternative they prefer. It is assumed that
the stated choices are congruent with decisions that
would be taken in similar situations in real life.
Comparisons between stated and revealed prefer-
ences in DCEs have mainly considered willingness to
pay (WTP), and often demonstrate a discrepancy be-
tween the stated and revealed preferences [9-13]. How-
ever, WTP is just one type of potential behaviour that
is studied in DCEs. Comparing stated preferences with
actual behaviour other than paying for a good orral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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the DCE-method.
In this study, parents were asked to decide whether to
vaccinate their new born child against hepatitis B. At the
time of the study, the hepatitis B vaccine had not yet
been introduced universally within the Dutch National
Immunization Program (NIP). We hypothesized that
stated preferences would correspond with actual choice
behaviour (revealed preferences). Traditionally, all vacci-
nations have had very high uptake in the Netherlands
(>95-97% of population is covered). However, recent vac-
cination campaigns showed uptake rates of around 50%
(for HPV vaccination) and are increasingly scrutinized in
public discussions (i.e., influenza vaccination).
The current study was conducted amidst growing con-
cerns about the acceptance of vaccination against human
papillomavirus (HPV) and H1N1 Influenza A in the
Dutch national immunization program (NIP) [14]. These
examples showed that people no longer accepted the
advice from the regulatory bodies without questions. As
a consequence, it is no longer straightforward that
people accept all vaccines that are offered in the context
of a NIP. After the decision to introduce universal hepa-
titis B-vaccination in the NIP was taken, the Ministry of
Health commissioned this study. At the time of the
study, only risk groups (new borns with a parent from
an endemic country, drugs users, men having sex with
men and commercial sex workers) were offered hepatitis
B-vaccination, while currently all new borns were eli-
gible for hepatitis B vaccination. The hepatitis B-vaccine
is part of a combination vaccine consisting of diphtheria,
pertussis, tetanus, polio and Haemophilus influenzae
type b and hepatitis B vaccine (DTaP-IPV-Hib-HepB orTable 1 Attributes and levels of the DCE, along with correspo
Attributes Variable nam
Infection Risk without vaccination INFR
Side effects of vaccination SIDE
Possibility to choose for hepatitis B or not CHOICE
Source of information that the vaccine is safe NIH
WFC
Source of information that the vaccine causes problems
(a child has been hospitalized after getting the vaccine)
SCM
ACQ
Attitude of social environment (Number of friends getting
their child vaccinated)
FRI6-valent vaccine). In order to test which factors may
influence the decision whether or not to accept this 6-
valent vaccine, we conducted a DCE. After completing
the DCE, we offered the same parents the 6-valent vac-
cine for their child, prior to the universal introduction of
this vaccine.
The aim of this paper is to study the congruence
between parents’ stated and revealed preference for vac-
cination of their new born child against hepatitis B.
Methods
Design of the choices
Table 1 presents all attributes, levels and the corre-
sponding questions from the questionnaire including the
recoding for further analyses. The selection of the attri-
butes was based on focus group interviews from a previ-
ous study with parents of new born babies concerning
the hepatitis B vaccine [15], literature review, and expert
interviews.
The first attribute (Infection Risk without vaccination,
in Table 1) refers to the importance of knowledge on the
a priori chance of getting hepatitis B infection without
vaccination. This was included in the design because
Brown et al. [5] found that the protection level of the
vaccine influenced the preference of mothers of daugh-
ters who were eligible for HPV vaccine [5]. The second
attribute (Side effects of vaccination) addressed the im-
portance of knowledge on the risk of side effects follow-
ing vaccination. This attribute was included because in
earlier studies it was found that the risk of side effects
affected girls’ preferences for vaccination [4,16]. The
third attribute (Possibility to choose for hepatitis B or
not) was included because parents indicated in the focusnding questions from the questionnaire
e Levels (coding in analyses)
(-1) unknown to you
(1) 1 to 500
(-1) unknown to you
(1) comparable to regular vaccination
(-1) you cannot choose whether to vaccinate your child with or
without the hepatitis B vaccine
(1) you can choose whether to vaccinate your child with or without
the hepatitis B vaccine
(0) GP
(-1) a folder by the National institute of health
(1) the child welfare centre
(0) the news on TV
(-1) social media (e.g. facebook, twitter, blog)
(1) acquaintance
(-1) none of your friends
(1) all of your friends
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cluded an attribute on the freedom of choice for parents
between a vaccine with hepatitis B (DTaP-IPV-Hib-
HepB) or without hepatitis B (DTaP-IPV-Hib). This im-
plies that an active choice can be made for a vaccine with
or without the hepatitis B component (see also [17]).
Paulussen et al. [18] emphasized that the reliability
and trustworthiness of the health care practitioners
might have an important influence on the decisions of
parents whether to have their child vaccinated or not,
this was confirmed by our experts. Therefore, an attri-
bute (Source of information that the vaccine is safe) that
consisted of three different sources stating that the
vaccine was safe, was included in the DCE. Previous
research found indications that various forms of infor-
mation exchange affect the uptake of vaccination.
Subsequently, we included an attribute on various
informal sources spreading a rumour that a child was
taken to hospital after being vaccinated (Source of infor-
mation that the vaccine causes problems (a child has
been hospitalized after getting the vaccine)). This attri-
bute was selected because it was found that after the
introduction of vaccination against cervical cancer for
12-year-old girls (with a catch-up campaign for girls
aged 13–16 years) in the Dutch NIP in 2009, national
media attention negatively affected the uptake of vaccin-
ation [19]. Van Keulen et al. described how information
exchange by girls on the internet led to fear of vaccin-
ation [20] and this was confirmed by our experts. Finally,
peer groups are known to affect attitudes towards vac-
cination [21]. Therefore, an attribute (Attitude of social
environment) on the vaccination behaviour of friends
and relatives was introduced.
Design of DCE, introduction of the scenarios
In total, the full factorial set consisted of 24*32 = 144 sce-
narios. We used random foldover to pair scenarios into
choice sets. This means that each scenario was randomly
paired with another scenario from the full factorial set,
resulting in 72 choice sets. The 72 choice sets were
blocked, resulting in 18 unique sets of four choice sets.
We repeated this foldover process to create 2000 unique
questionnaires.
The DCE consisted of four choice sets per respondent;
each choice set contained two unlabelled scenarios. Par-
ents were asked to choose between the two scenarios.
Subsequently, they were asked to state how certain they
were about their choice on a 10-point scale anchored by
the statements “I am certain that I would not have my
child vaccinated in this situation” and “I am certain that
I will have my child vaccinated in the chosen situation”.
The choices were introduced with a detailed description
of the case. An illustration of the DCE is displayed in
Additional file 1.The DCE was part of a questionnaire that included
questions on psychological and social characteristics.
The questionnaire included questions on the respon-
dents’ estimation of the protection of the vaccine, side
effects, opinion on combining standard vaccination with
hepatitis B vaccination, their use of both formal and
informal sources of information, and on vaccination be-
haviour of others in their social network. The question-
naire also gathered information on socio-demographic
characteristics of the respondents.
Study population
The study population consisted of parents with a new-
born younger than two weeks that was not yet eligible
for hepatitis B vaccination (i.e. new-borns that did not
belong to risk groups). A random sample of 2000 ad-
dresses of these new-borns was taken from a national
database that is used to send invitations to parents for
the NIP (Praeventis database). Vaccination status is reg-
istered in this database as well. The parents did not
receive specific additional information on hepatitis B,
which is in line with current standards within the NIP.
In the questionnaire, respondents were asked whether
they wanted to participate in a follow up study, without
reference to the character of this follow-up study. People
who indicated their willingness to participate in the
follow-up study received a letter after four weeks with
the offer to have their child vaccinated against hepatitis
B. They were free to reject the offer. The letter was
accompanied by additional information, an informed
consent form and a letter to their GP (please see also
[22] for elaborate description of the process of data col-
lection). Parents who opted for the 5-valent hepatitis B
vaccine, enrolled in the regular program and did not
need a special voucher.
Observation of revealed preferences
For the parents who returned the informed consent
form, we extracted vaccination decision (with or with-
out hepatitis B) from the National Praeventis database
of the NIP. As there is some fluctuation in the timing
of uptake of the first vaccination within the NIP, the
actual vaccination behaviour was checked 2.5 months
after the invitations were sent, to make sure that most
babies would have had their first vaccination. The In-
stitutional Review Board of the University Medical
Centre Utrecht approved the study.
Analyses
Step 1: computing individual preference to accept
vaccination or not, based on DCE
The answer to the question how certain the respondent
was that their child would be vaccinated after making
the choice between scenarios was used to identify the
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below 6, the respondent was coded to have chosen the
opt-out in that choice set.
The subsequent data from the DCE were analysed
with mixed logit, using NLogit 5.0. The attribute levels
were effects coded (see Table 1 for precise coding). The
test for the necessity of random parameters, based on
log likelihood improvement, resulted in the following
parameters being set random, assuming a normal distri-
bution: The effectiveness of the vaccine, the side effects
of the vaccine and the source of information that the
vaccine causes problems (both social media and ac-
quaintance). The following equations were tested:
VA=B ¼ b0;i þ b1;iINFR þ b2;iSIDE þ b3CHOICE
þb4NIH þ b5WFC þ b6;iSCM
þb7;iACQþ b8FRI
V opt−out ¼ 0
V is the deterministic utility of the choice and can be
calculated as the observed utility which is the sum of β0
(the intercept) and β1 – β8, which are the attribute esti-
mates that indicate the relative importance of each
attribute.
The model presented in the equation was estimated.
The potential vaccination coverage rate was estimated at
population level for the following vaccine scenario: the
effect of the vaccination is known (INFR = 1), the risk of
side effects is comparable to regular vaccination (SIDE = 1),
people have no choice (CHOICE = −1), the National Insti-
tute of Health advices to use the vaccine (NIH = 1), the
child welfare centre advices to use the vaccine (WFC = 1),
a social media notification of hospitalization of a child
after vaccination (SCM = 1), this story is also told by
acquaintances (ACQ = 1) and all friends take the vac-
cine (FRI = 1).
The potential coverage rate can be calculated as 1/
(1 + exp-v). Since V includes random parameters, the
standard deviation of those parameters should be
accounted for [8,23]. The value of the random parame-
ters was determined by taking 10,000 draws from a nor-
mal distribution with a mean and standard deviation
(SD) for that particular random parameter (i.e., the mean
and SD values were retrieved from the mixed logit
model). For every draw of the random parameter value,
the observed utility ‘V’ as well as the potential coverage
rate was calculated. The average of the 10,000 calculated
potential vaccination coverage rates was reported.
Second, the individual-level beta values were stored by
Nlogit software for all random variables (i.e., the inter-
cept, effectiveness, side-effects, and the source of infor-
mation). These individual beta values were then used to
compute the utility for the vaccine scenario described
above. This resulted in a utility score for this particularscenario for every respondent separately. Subsequently,
the individual utility scores were compared to the utility
of the opt-out option. If the utility of the scenario was
larger than the utility of the opt-out, the respondent was
assumed to opt for vaccination, and vice versa.
Step 2: comparing the predictions with actual behaviour
The individual-level stated preferences with respect to
hepatitis B vaccination from step 1 were compared to
the observed behaviour in a 2×2 table. Predictions were
marked as correct, when the predicted acceptance of
hepatitis B vaccination by the parents corresponded with
the children’s vaccination status (yes/no) as recorded in
the database of the NIP.
Positive predictive value and Negative predictive value
In order to interpret the value of the predictions, we cal-
culated the positive predictive value (PPV) and negative
predictive value (NPV). The terms “positive predictive
value” and “negative predictive value” are mostly used in
diagnostic testing [24]. The PPV of a test is defined as
the proportion of people with a positive test result who
actually have the disease. The NPV of a test is defined as
the proportion of people with a negative test result who
actually do not have the disease. In this study, the PPV
expresses the proportion of respondents who were con-
gruent in their stated and revealed preference in accept-
ing the vaccination; the NPV expresses the proportion of
respondents who were congruent in their stated and
revealed preference in rejecting the vaccination.
Results
Study population and response
Of the 2000 questionnaires, 906 were returned (response
rate = 45.3%). Six respondents were not included in the
analyses because they stopped completing the question-
naire already at the demographic variables. An additional
four were not included because they had not answered
any of the choice sets. Eleven respondents with missing
values on some but not all of the choice sets were
included. This resulted in 7,132 observations (scenarios
assessed) in 896 respondents.
The mean age of the respondents was 31.5 years,
(range 16–48 years) (see Table 2). Of the respondents
82% were female. Of all respondents, 90% reported no
conviction or religion that influenced their opinion on
vaccination, while 6% reported that their religious con-
viction affected their opinion on vaccination. In the
Netherlands, about 1.3% of the population belongs to
orthodox protestant subgroups [25]. These groups re-
fuse vaccination because it presumably interferes with
God’s will [26,27]. Finally, 4% reported that other con-
victions influenced their attitude to vaccination (2%
homeopathy, 1% nature medicine or anthroposophy,
Table 2 Descriptive statistics sample
Mean (s.d.) %
Gender female 81.8




No religious conviction 90.0
Religious conviction that affects vaccination choice 6.0
Other conviction that affects vaccination choice
(homeopathy, nature medicine or anthroposophy)
4.0
Newly born child firstborn child = yes 52.2
Bad experience vaccination first child (for those
eligible)
1.2
Table 3 Results mixed logit, predicting preference of
vaccination behaviour in DCE
b (s.e.) Sd for random
parameters (s.e.)
Constant -2.77 (0.71)** 4.55 (1.06)**
Infection Risk without vaccination
Unknown to you -0.34
1 to 500 0.34 (0.05)** 0.32 (0.29)
Side effects
Unknown to you -0.39
Comparable to regular vaccination 0.39 (0.06)** 0.67 (0.18)**
Choice
No choice offered for hepatitis B
or not
-0.18
Choice offered for hepatitis B or
not
0.18 (0.04)**
Source of information that the
vaccine is safe:
General Practitioner -0.06
National Institute Health -0.19 (0.06)**
Child welfare centre 0.25 (0.06)**
Source of story hospitalization of
child:
TV news 0.38
Social media -0.20 (0.05)** 0.12 (0.29)
Acquaintance -0.18 (0.06)** 0.64 (0.25)*
Attitude of social environment:
No friend vaccinates -0.70
All friends vaccinate 0.70 (0.06)**
Log likelihood -3464.02
AIC 1.97
** = p<0.01; *p<0.05 (log likelihood null model -3897.87).
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ation because of the potential harm the vaccination
presumably causes to the body. Almost half (48%) of
the respondents reported positive previous experiences
with vaccination, while about 1% of the respondents
reported negative experiences with vaccination.
Results step 1: the model on DCE data
In total 3,566 choice sets (7,132 scenarios) were used for
the analysis. Table 3 presents the results of the mixed
logit model of the DCE. The middle column presents
the beta values of the mixed logit analyses. The right
column of Table 3 presents the standard deviations
(assuming a normal distribution) for the parameters with
random slopes (intercept, the infection risk without vac-
cination, side effects and the source of the story of
hospitalization of a child). The fact that these standard
deviations are significant implies that preference hetero-
geneity is present for these attributes amongst the
respondents.
All the coefficients of the betas are significant (p <
0.01). The largest coefficient was found for attitude of
social environment (b = 0.70; s.e. = 0.06), so friends vac-
cinating their children strongly affect the choice for
vaccination among respondents. Two other important
factors that affect the decision to vaccinate are ‘know-
ledge that the risk of possible side effects is compar-
able to regular vaccination’ (b = 0.39, s.e. = 0.06) and
‘knowledge of the a priori risk of getting hepatitis B
without vaccination’ (b = 0.34, s.e. = 0.05). Furthermore,
informal sources of information reporting on problems
with the vaccine affect vaccination decisions. When so-
cial media report a child being admitted into a hospital
after vaccination or when an acquaintance reports this
(b = −0.20, s.e. = 0.05 and b = −0.18, s.e. = 0.06, respect-
ively), the willingness to vaccinate is less than when the
story originates from official news sites.Next, people prefer to have a possibility to choose
between a vaccine with or without the hepatitis B com-
ponent (b = 0.18, s.e. = 0.04), but this is less important in
the vaccination decision than the other characteristics.
Concerning the (formal) sources of information that the
vaccination is safe, all sources have a relatively small
impact on the choice of the respondents. However, of
the formal sources, the clinician of the child welfare cen-
ter has some positive influence compared to the GP (b =
0.25, s.e. = 0.06), while communication by the National
Institute of Public Health has a negative influence on the
willingness to have a child vaccinated, compared to com-
munication by the GP (b = −0.19, s.e. = 0.06).
Results step 2: comparing the stated and revealed
preferences
The real uptake (revealed preferences) of the Hepatitis B
vaccine in the sample is 84% (Table 4). On population
Table 4 Comparison of stated and revealed preferences
Stated preference
Not vaccinate Hep B Vaccinate Hep B
Revealed preference Not vaccinate Hep B 6 33 39 (16%)
Vaccinate Hep B 17 191 208 (84%)
23 (9%) 224 (91%) 247
(0 = choice against vaccination; 1 = choice for vaccination).
Cohen’s kappa = 0.09 (approx. T = 1.54, ns).
Lambooij et al. BMC Medical Research Methodology  (2015) 15:19 Page 6 of 8level, a coverage rate of 76% (95% CI: 44%-94%) was
estimated for a vaccination scenario that closely resem-
bles the situation in real life.
Table 4 presents the cross table of the computed
stated preference and the revealed preference of the 247
respondents we included in the analyses. The table
shows that 224 responders (91%) have a higher utility
for the vaccination scenario than for the opt-out, and
thus a stated preference of choosing for vaccination. For
23 responders (9%), the utility for opt-out was larger
than the utility for the scenario.
The main diagonal of Table 4 represents the number of
respondents with correspondence between stated and re-
vealed preferences. Overall, 197 (191 + 6) decisions were
predicted correctly (80%). In 33 cases (13%), vaccination
was predicted but not received. In 17 cases (6%) it was
predicted that parents would not have their child vacci-
nated against hepatitis B, while in reality they accepted
the vaccination offer.
Table 4 further shows that a majority of people ac-
cepted the Hepatitis B vaccination (84%), while a minor-
ity deviated from this behaviour and did not get the
vaccination (16%). This asymmetry in the distribution of
the vaccination behaviour is the cause of the Kappa
measure being non-significant, despite the percentage of
correct predictions [28,29].
In our case, the PPV is 85% (191/224 = 85%) and the
NPV is 26% (6/23 = 26%).
Discussion
The aim of this paper was to study the predictive value
of the DCE-technique by comparing stated with revealed
preferences among parents deciding whether or not to
vaccinate their new born child against hepatitis B. For
247 parents, predicted vaccination behaviour was com-
pared with their actual choices regarding vaccination of
their new born against hepatitis B. In 80% of the respon-
dents, their actual behaviour was predicted correctly by
the stated preference DCE. The positive predictive value
was 85% and the negative predictive value was 26%.
Previous research in health care that compares stated
and revealed preferences of patients, was conducted by
Ryan and Watson [30,31]. That study compared the
results of a DCE that used multiple hypothetical scenar-
ios to the real life choice to participate in chlamydiainfection screening. The study found 81% correspond-
ence between the stated and revealed preferences. The
authors concluded that their predictions overestimated
real behaviour and that more research was needed [31].
The percentage of correct predictions in the current
study is similar to that study, and in direct comparison
between the stated and revealed preferences, we also
find an overestimation (predicted 91% vs 84% observed),
but in the aggregate estimated uptake, we found an
underestimation (76% estimated uptake).
In current DCE research, the different attributes are in
general interpreted as attributes of goods or of a product
that respondents trade off against one another. We
included not only attributes of vaccination itself (such as
side effects and effectiveness), but also attributes that
refer to the physical (location of vaccination) and social
environment in which the vaccination is given. Although
the latter attributes may be relevant in the decision of
parents, they cannot be influenced by health policy
makers that aim to offer a vaccination programme with
high acceptance levels. Therefore, our attributes should
be interpreted as factors that influence decisions that
respondents make, rather than as characteristics that
can be traded among each other.
We obtained data and informed consent to compare
the stated and revealed preferences for only 247 of 906
(27%) respondents. A selection bias in this group may
have distorted our results. We compared the group of
respondents that consented to participate with the group
of respondents that did not agree to participate in the
second stage of the study with regard to educational
level, presence and number of other children in the fam-
ily, and presence of (religious) convictions (not shown).
Both groups did not differ with regard to the presence of
(religious) convictions or number of previous children,
but the group that allowed us to study revealed prefer-
ences was more highly educated. Additional analyses
(not shown) with a mixed logit model of the sample of
people who allowed us to compare their stated prefer-
ence with their revealed preference, show that the gen-
eral preference of this group is more positive towards
vaccination.
In this study we used a dual-response response design
with a scale to indicate the respondents’ certainty of the
answer. Research found no differences between the dual-
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[32]. Because of the scaled certainty question, we had to
make a choice for the dichotomization of the scores into
either opt-in (acceptance of vaccination) and opt-out
(refusal of vaccination). We decided to make the cut off
at the centre of the 10 point-scale (between 5 and 6). In
order to test how this affected the answers, we analysed
the answers leaving out the choices with a value 5 or 6
on the scale (analyses not shown). We found that the
general answer patterns remained similar.
Even though the percentage of correct predictions is
encouraging, the respondents turned out to behave more
similarly than expected. The large majority chose to have
their child vaccinated against hepatitis B. In 7% we pre-
dicted that people would not get the vaccination with
Hepatitis B, while they did, whereas in 13% we predicted
that they would get the vaccination, while they did not
(Table 4). A possible explanation for people unexpectedly
accepting the vaccination could be that participation in
the study encouraged the respondents to inform them-
selves about the topic and change their point of view.
A possible explanation for people unexpectedly not
accepting the vaccination may lie in the disturbance
caused by the amount of study-induced information that
was included with the request to participate in the sec-
ond phase of the study. At the instigation of the Institu-
tional Review Board, the researchers had to add a letter
to the second phase of the study (where the real vaccine
was offered), asking parents to inform their family
doctor when they chose to vaccinate their child. Also,
despite the fact that the hepatitis B vaccine has been
safely administered to millions of new-borns worldwide,
the Institutional Review Board only allowed this study
when information material accompanying the offer to
vaccinate emphasized that insurance covered possible
harm caused by the study. This may have discouraged
some parents who initially may have intended to accept
the vaccination offer.
Although this study adds to the knowledge on the
relationship between stated and revealed preferences, it
does not provide a definite answer with regard to exter-
nal validity of DCEs. The behaviour in this study was
very asymmetric (most people chose the vaccination)
only yielding evidence of acceptable predictive validity in
a situation of a population largely accepting the vaccin-
ation. If possible, our study should be repeated with a
health behaviour that shows more variation in a popula-
tion. This could for instance be tested in HPV vaccin-
ation, were acceptance levels are around 50% in the
target group of adolescent girls [33].
Conclusions
The added value of this study is the unique combination
of data on the stated preferences of respondents andobservations of their actual behaviour. We found some
evidence that the stated preferences we measured were
related to the actual behaviour of respondents, and that
the positive predictive value was satisfactory. However,
due to the skewed distribution in the behaviour, the
negative predictive value was low. To further study the
relationship between stated and revealed preferences, a
similar study on a different type of (health) behaviour
should be conducted, preferably on behaviour that shows
more variance within the population.
Additional file
Additional file 1: Example of introduction and choice set.
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